These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17598435)

  • 101. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S
    Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women.
    Fontalba A; Gutiérrez O; Llorca J; Mateo I; Berciano J; Fernández-Luna JL; Combarros O
    Dement Geriatr Cogn Disord; 2008; 26(3):247-50. PubMed ID: 18841008
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
    Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P
    J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW
    N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
    [No Abstract]   [Full Text] [Related]  

  • 110. N-acetyltransferase phenotype of patients with cancer of the larynx.
    Drózdz M; Gierek T; Jendryczko A; Pilch J; Piekarska J
    Neoplasma; 1987; 34(4):481-4. PubMed ID: 3658048
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
    Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
    Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
    Nair CR; Gupta RC; Varshneya AK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
    Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
    Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 116. [Acetylation phenotype in glomerulonephritis and its clinical significance].
    Milejski P; Orzechowska-Juzwenko K; Strychowski J; Szewczyk Z; Klinger M
    Pol Tyg Lek; 1987 May; 42(18):537-40. PubMed ID: 3628088
    [No Abstract]   [Full Text] [Related]  

  • 117. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S; Väkevä A; Hiltunen M; Soininen H
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Features of the metabolic activity of the mononuclear phagocytic system in multiple sclerosis patients].
    Kovalev IE; Kovalev EN; Seleznev NG; Kuvshinova RL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):198-201. PubMed ID: 6711206
    [TBL] [Abstract][Full Text] [Related]  

  • 119. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.
    Arias TD; Inaba T; Cooke RG; Jorge LF
    Clin Pharmacol Ther; 1988 Sep; 44(3):343-52. PubMed ID: 3416554
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.